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Original Article 
IMMUNOHISTOCHEMICAL IDENTIFICATION AND DISTRIBUTION  
OF GLUTAMATERGIC NMDA AND mGlu1 RECEPTORS  
IN THE PONTINE INTERTRIGEMINAL REGION IN RATS 
Milan Stoiljkovic   
Department of Pharmacology and Toxicology, University of Niš, Faculty of Medicine, Niš, Serbia 
Abstract. Local glutamate simulation of intertrigeminal region (ITR) in the lateral pons evoked immediate 
cardiovascular and respiratory effects proposing its role in central cardiorespiratory control. Since pharmacological 
studies provided only functional evidence for the existence of glutamate receptors in the ITR and thereby specifying 
putative neurochemical substrate involved in this control, here we employed immunohistochemistry to examine 
expression and distribution of NMDA and mGlu1 receptors in this structure. Thirty adult male Sprague-Dawley rats 
were perfuse-fixed, their brains frozen and cut into sequential series of 20 µm thick sections through the ITR. 
Immunohistochemistry was performed using polyclonal antibodies against NMDA-NR1, NMDA-NR2A and mGlu1 
receptors. Labeled neurons in the ITR were analyzed using light microscope and computerized image analysis system 
for quantification of relative immunoreactivity as the mean of integrated optical density (IOD), and counting the 
immunopositive cells. Light microscopic analyses demonstrated NMDA-NR1-immunoreactivity mainly localized in the 
neuronal cell bodies with sparse distribution on primary dendrites, while NMDA-NR2A-immunoreactivity was 
basically somatically distributed. The mGlu1-immunoreactivity was moderate and observed both in neuronal bodies 
and primary dendrites or extracellular matrix suggesting somatodendritic localization. Quantitative analyses of IOD 
showed very strong expression of NMDA-NR1, weak of NMDA-NR2A and strong-to-moderate expression of mGluR1, 
with differences in immunostaining signal distribution over rostro-caudal span of the ITR. Counting of 
immunopositive cells followed similar expression profile. Our data directly confirm the presence of glutamatergic 
NMDA and mGlu1 receptors in the ITR apparently involved in signaling pathways by which this region modulates 
cardiorespiratory functions such as blood pressure, heart rate and breathing. 
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Introduction

 
Dorsolateral pontine neurons located in the intertri-
geminal region (ITR), parabrachial complex (PB) and 
Kölliker-Fuse nucleus (KF) are important components 
involved in cardiorespiratory coupling, a dynamic prop-
erty of homeostasis involved in control of blood pres-
sure, heart rate and breathing [1, 2]. This coupling de-
pends mainly on local circuitries and direct anatomical 
connectivity within these neurons and their inputs to 
forebrain structures involved in regulation of respiratory 
and cardiovascular functions [3, 4].   
Previous studies posited particular role of glutama-
tergic neurotransmission for proper synchronization 
between breathing and cardiovascular dynamics as glu-
tamate is shown to be essentially involved in both as-
cending and descending pathways of sympathetic res-
piratory and cardiovascular inputs [5]. In addition, evi-
dence based on detection of mRNA by in situ hybridi-
zation suggests that a large proportion of the brainstem 
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neurons that contribute to respiratory and cardiovascular 
functions and presumably in their coupling are glu-
tamatergic i.e. positive to vesicular glutamate trans-
porter-2 [6, 7]. Indeed, it has been shown that local mi-
croinjections of glutamate into the PB, KF or ITR neu-
rons elicit transitory cessation of breathing and increase 
in arterial blood pressure in anesthetized rats [1, 813]. 
While further neuroanatomical investigations of PB/KF 
nuclei confirmed glutamate receptor subtypes involved 
in these effects [10, 1418], no morphological evidence 
exist to support presence of specific glutamate receptors 
in the ITR. In the set of previous pharmacological stud-
ies of ITR using subtype-selective antagonists of gluta-
mate receptors only functional evidence for their exist-
ence therein was provided [12, 1921]. Therefore, in the 
present study immunohistochemistry was performed 
using specific antibodies against NMDA (-NR1 and -
NR2A) and mGlu1 glutamate receptors in order to de-
termine distribution and expression patterns of these 
receptors within the ITR. 
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Methods 
All experimental procedures were reviewed and ap-
proved by the local bioethics committee and conducted 
in compliance with the principles outlined in the EU and 
USA guidelines on the protection of animals used for 
scientific purposes (Directive 2010/63/EU and NIH 
Publications No. 80-23, revised 1996). Thirty adult male 
Sprague-Dawley rats (270-300 g) were kept individually 
in standard cages in a temperature and humidity-con-
trolled environment under a 12:12 h light/dark cycle and 
with unlimited access to food and water. All efforts 
were made to minimize the number of animals used and 
their suffering.  
To obtain brain tissue, animals were deeply anesthe-
tized with the combination of ketamine 80 mg/kg and 
xylazine 5 mg/kg given intraperitoneally and transcardi-
ally perfused with 150 ml of cold 0.9% saline contain-
ing 1 U/ml heparin, followed by 200 ml of 4% freshly 
prepared paraformaldehyde in 0.1 M phosphate buffer 
saline (PBS, pH 7.4) as a fixative. This method is con-
sistent with the recommendations of the Panel on Eu-
thanasia of the American Veterinary Medical Associa-
tion. Immediately following perfusion, brains were re-
moved from the skull, post-fixed
 
in the same fixative for 
2 hours, and then cryoprotected by immersion in 30% 
sucrose in 0.1 M PBS at 4°C for several days. For tissue 
processing the brainstem blocks were frozen and cut 
into an sequential series of 20 µm-thick coronal sections 
using a cryostat microtome (Leica CM 1850, Nussloch, 
Germany) and collected consecutively into three serial 
screen-bottom trays immersed in cold 0.01 M PBS (pH 
7.4). Thus, for each rat, approximately 25 sections were 
collected and equally spaced in three series (about 60 µm 
apart) for the entire pontine ITR. This allowed systematic 
examination of distribution of glutamate receptors’ 
immunoreactivity in the rostro-caudal extent of the 
structure (-9.16 mm to -9.80 mm from bregma), according 
to rat brain atlas [22]. One section from every group of 
serial sections was used for immunostaining against 
NMDA-NR1, -NR2A, or mGlu1a receptors, while the 
others serve as a specificity control of labeling or processed 
for cresyl violet Nissl staining to examine the 
morphological features of the ITR. All sections from each 
alternate series were processed under identical conditions 
(i.e. time, temperature, and concentration of reagents). 
Immunohistochemistry was carried out using poly-
clonal rabbit anti-NMDA-NR1, polyclonal rabbit anti-
NMDA-NR2A and polyclonal goat anti-mGlu1a anti-
bodies as well as corresponding secondary biotinylated 
antibodies, all purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA). Briefly, the free-floating 
sections were treated with 3% H2O2 for 10 min to sup-
press endogenous peroxide activity, followed by 2% 
normal serum for 30 min at 37 ºC to block nonspecific 
binding sites. Then the sections were incubated with 
polyclonal anti-NMDA-NR1 (sc-9058), anti-NMDA-
NR2A (sc-9056) or anti-mGlu1a (sc-47130) antibodies 
at 4ºC overnight. The primary antibodies were diluted 
1:100 in a carrier containing 2% normal serum in 50 
mM Tris-buffered saline (TBS, pH 7.4). Thereafter, 
appropriate biotinylated secondary antibodies diluted 
1:300 in the same carrier as primary antibodies, and 
avidin-biotin-peroxidase complex solution (Vectastain 
Elite Kit, Vector Laboratories, Burlingame, CA, USA) 
diluted 1:100 in TBS, were applied to the sections for 
30 min each at room temperature. Between each of the 
steps, 50 mM TBS (pH 7.4) with 0.05 % Triton X-100 
was used to thoroughly rinse the sections three times for 
10 min by swaying. Immunoreactivity was detected by 
processing sections first with 0.05% 3,3-diaminobenzi-
dine tetrahydrochloride (DAB, Sigma, St. Louis, MO, 
USA) in TBS-Triton (pH 7.7) for 5 min, and then with 
addition of equal volume of DAB containing 0.01% 
H2O2 for the next 5 min at room temperature. The reac-
tion was stopped by transferring the sections in ice-cold 
TBS and rinsing. Finally, the sections were mounted 
onto gelatin-coated slides, dehydrated, cleared, and 
sealed. Labeled sections were analyzed using Axio Ob-
server Z1 microscope (Carl Zeiss, Göttingen Germany), 
linked to camera. Captured images were analyzed by 
computerized image analysis system (Image J, NIH, 
Bethesda, USA) for quantification of relative protein 
levels as the mean of integrated optical density (IOD) 
and for counting the immunopositive cells.  
All antibodies used in the study (anti-NMDA-NR1, 
anti-NMDA-NR2A and anti-mGlu1a) were well char-
acterized and their specificities established by the manu-
facturer. The rabbit polyclonal anti-NMDA-NR1 and anti-
NMDA-NR2A antibodies are purified immunoglobulins 
raised against amino acids 19-318 or 23-76 mapping 
within an extracellular domain of human NMDA-NR1 or 
NMDA-NR2A, respectively. By Western blot analysis, 
anti-NMDA-NR1 antibody specifically yielded single 
bands between 100 and 150 kDa in mouse brain extract. 
Specificity of anti-NMDA-NR2A antibody was confirmed 
by a single band at the expected molecular size (200 kDa) 
in Western blots of H4 whole cell lysate. The goat 
polyclonal anti-mGlu1a antibody is an affinity purified 
immunoglobulin raised against a peptide mapping within 
an extracellular domain of mGluR1 of human origin. 
These antibodies have also been successfully used by 
several groups (for NMDA receptors see: [23, 24]; for 
mGlu1a receptors see: [25, 26].  
Set sections adjacent to those processed for im-
munohistochemistry were used to verify the specificity 
of the labeling. This was achieved by running some 
slides in parallel through the entire procedure with the 
omission of the primary antibodies. No staining was 
observed in these control sections. As an additional 
control, the staining pattern obtained in this study was 
compared with previously published data on the distri-
bution of NMDA-NR1 and mGluR1a immunoreactivity 
in the distinct brain regions. For instance, our NR1-
stained sections shown strong immunoreactivity in the 
hippocampus and hypothalamus as found by Petralia et 
al. [27], whereas strong mGluR1a-immunoreactivity was 
exhibited in the cerebellar cortex (molecular and Purkinje 
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cell layers), as reported by Baude et al. [28]. The third 
series of the sections were processed with Nissl cresyl 
violet method in order to assess the cytoarchitectonic 
boundaries of the ITR using rat brain atlas [22]. 
For quantitative analysis of NMDA-NR1, NMDA-
NR2A and mGlu1a receptor-like immunoreactivity in 
the ITR, the comparative sections were digitally photo-
graphed under the same exposure condition and ana-
lyzed using microscope-based image-analysis system 
ImageJ. Low power images (5 x objective) were used to 
outline the ITR and order sections from rostral to caudal 
level relative to bregma. For each rat, an average of ten 
immunostained sections were sampled at a high magni-
fication (40 x objective) and converted to binary im-
ages. To calculate the number of immunoreactive cells 
in each section and to measure the intensity of the im-
munoreaction by optical densitometry an unbiased 
counting frame of 100 µm x 100 µm was used. This 
allowed assessment of changes in the number of ex-
pressing cells and the relative amount of the peptides. 
Approximately the same level of the ITR was chosen 
for every antibody and receptor-like immunoreactivity 
was consider positive for NMDA-NR1, -NR2A or 
mGlu1a if punctate staining was observed within the 
cell body or along the dendritic processes. To prevent 
multiple counting, neurons from every third evenly 
spaced section were included in the analysis and only 
immunopuncta inside the counting frame or touching its 
upper or right edge were counted. The counting was 
repeated at least twice for each section analyzed, which 
ensured that the number of profiles obtained was similar. 
Since light intensity can directly affect optical den-
sitometric values for all of the measurements, lighting 
conditions were held constant all the time. Details re-
garding methodology for image processing and calibration 
were taken from publication by Jovanovic et al.  [29].  
Statistical analyses were done using one-way analy-
sis of variance and Student’s t-test. Data are expressed 
as mean ± SEM, and difference consider significant if p 
< 0.05. 
Results 
Light microscopic analyses demonstrated a very strong 
homogenous positive staining in all sections investi-
gated through different levels of ITR. Immunoreaction 
product was generally present in both cell bodies and 
proximal dendrites of labeled neurons as well as in the 
neuropil, mainly in dendritic processes. Immunoreac-
tivity of NMDA-NR1 was predominantly located so-
matically since plasma membrane of many labeled neu-
rons showed clearly visible immunoreaction product 
(Fig. 1). Fewer neurons also displayed NMDA-NR1 
 
Fig. 1 Coronal sections of rat brain at the level of pontine ITR processed using specific antibodies against NMDA-
NR1 and -NR2A receptors. Immunopositive reaction was detected in the cytoplasm of neurons and sparcely in 
the primary dendrites (arrowheads). Magnification (by objective): A (x 5), B (x 20), C-E (x 63). 
Abbreviations: ITR (intertrigenimal region), Pr5 (principal sensory trigeminal nucleus), Mo5 (motor 
trigeminal nucleus), LPB (lateral parabrachial complex nuclei).  
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positive immunoreaction on long thin profiles, which 
are presumably primary dendrites (Fig. 1C, D). At high 
magnification, NMDA-NR2A immunoreactivity con-
sists of discrete products predominantly distributed in 
the soma of neurons scattered in the ITR (Fig. 1E). In 
mGlu1a labeled neurons immunoreactivity was rather 
homogeneously present both on primary dendrites and 
in the neuronal cell bodies (Fig. 2). In these sections, 
moderate fiber immunoreactivity with no apparent cel-
lular staining was also noticed. Overall, both somatic 
and dendritic staining was observed (Fig. 2C, D, E). 
Control sections had no specific immunoreactivity 
above background (data not shown). 
Quantitative analyses of immunostained sections at 
the same level of ITR from each rat revealed differences 
in NMDA-NR1, -NR2A and mGlu1a with respect to la-
beling intensity and numbers of labeled neurons. The 
most prominent staining intensity is for NMDA-NR1, 
moderate for mGlu1a and weak for -NR2A as measured 
by integrated optical density (Fig. 3). For both NMDA-
NR1 and mGlu1, densest immunoreaction was distrib-
uted in medial part of the ITR, i.e. in sections extending 
from -9.30 to -9.68 mm relative to bregma. In the most 
caudal sections, i.e. -9.80 mm relative to bregma, appar-
ently smaller numbers of neurons were stained for 
mGlu1 comparing to NMDA-NR1. Moreover, expres-
sion of the -NR2A immunoreactivity was significantly 
lower (p < 0.05) than for the other two receptor sub-
types throughout the ITR. Similar results were obtained 
for counting immunoreactive cells for each receptor 
subunits analyzed at the same rostro-caudal level of the 
structure as summarized in Table 1. 
 
Fig. 3 Quantification of expression of NMDA-NR1, 
NMDA-NR2A and mGlu1 specific proteins 
using integrated optical density (IOD) at the 
level of ITR. Results are expressed as mean  
SEM for IOD at every rostrocaudal level of 
every analyzed ITR sections (*p < 0.05).   
 
Fig. 2 Coronal sections of rat brain at the level of pontine ITR processed using specific antibodies against mGlu1 
receptors. Immunopositive reaction was detected both in the cytoplasm of neurons and in primary dendrites 
(arrowheads). Magnification (by objective): A (x 5), B (x 20), C (x 40) D-E (x 63). Abbreviations: ITR 
(intertrigenimal region), Pr5 (principal sensory trigeminal nucleus), Mo5 (motor trigeminal nucleus).  
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Table 1 Number of immunopositive neurons for 
glutamatergic NMDA-NR1, NMDA-NR2A and 
mGlu1 receptors in the whole rostro-caudal 
dimension of the ITR.  
Rostro-caudal 
dimension of ITR 
NMDA-NR1 NMDA-NR2A mGlu1 
-9.16 mm 86  18 21  17 43  25 
-9.30 mm 111  21 35  18 73  28 
-9.68 mm 91  23 26  12 77  36 
-9.80 mm 53  14 28  14 54  18 
Results are expressed as mean  SEM immunopositive 
neurons in the rostro-caudal span of the ITR. Caunting 
sections were determined relative to bregma using rat brain 
stereotaxic atlas [22]. Overall lower number of NR2A 
immunopuncta was found in the ITR structure comparing to 
those for NR1 or mGlu1 receptors. 
Discussion 
Using light microscopic evaluation and IOD quantitative 
analyses of NMDA-NR1, -NR2A and mGlu1a immuno-
positive puncta, we showed here that glutamatergic 
NMDA and mGlu1 receptors are clearly expressed in the 
ITR. This is of particular importance since it represents 
the first direct confirmation of these receptors in the ITR, 
whose functional existence was previously suggested in a 
set of pharmacological studies with specific antagonists 
[12, 20, 21]. Moreover, our study revealed distribution of 
these receptors within the whole extent of ITR structure, 
as well as their specific localization at neuronal level that 
is necessary to delineate synaptic mechanisms involved in 
its cardiorespiratory control.   
Previous immunohistochemical studies [23, 30] have 
shown that expression of -NR1 subunit could serve as a 
reliable marker of NMDA receptor presence in the brain 
since it is core component of the functional NMDA re-
ceptor complex. Our analysis of the ITR at the light 
microscopic level, showed that NMDA-NR1 and -
NR2A immunopositive puncta are predominantly lo-
cated in neural cell bodies, with sparse neuropilar (at the 
primary dendrites) and extracellular matrix distribution 
within the ITR. On the other hand, mGlu1 immunoposi-
tivity was present on neural-dendritic sites since it is 
equally distributed both in neuronal cytoplasm and pri-
mary dendrites. Overall, the distribution
 
of NMDA-NR1 
subunit was quite similar to that of mGlu1a, however, 
the pericellular labeling that characterized
 
some of the 
immunoreactive neuropil structures outlining the soma 
and proximal dendrites of ITR neurons was not en-
countered
 
in the NR1-immunostained material. Fur-
thermore, using quantitative IOD analysis of immuno-
labeled neurons with subtype-specific antibodies, we 
detected different degree of expression of these neurons 
within the ITR. More specifically, we found intense 
expression of -NR1, intense-to-moderate of mGlu1, and 
quite low expression for -NR2A proteins. These results 
further confirmed our light microscopic findings, and 
also suggest relatively higher density of NMDA com-
paring to mGlu1 receptors in the structure. Thus, ITR 
functional NMDA receptor complexes are most likely 
composed of NR1/NR2A subunits given their similar 
neuronal distribution. This aligns with the previous 
findings of similar NMDA complexes in the neighbor-
ing pontine structures, as well as with the evidence of 
their predominant expression in the pontomedullary 
region during postnatal development [31-33]. Based on 
histological and ultrastructural colocalization for -NR1 
and -NR2A subunits in various neuronal populations, 
Petralia et al. [27] concluded that this type of NMDA 
receptor complex is mainly postsynaptically localized. 
Accordingly, NMDA receptors identified in our study 
are presumably postsynaptic receptors. Presence of 
mGlu1 immunopositivity in the ITR is also in correla-
tion with previous study where their expression in lat-
eral pontine PB and KF neurons was described [17]. 
However, exact synaptic localization of these receptors 
is difficult to reveal using conventional light micro-
scopic examination, particularly when immunopositive 
puncta are visible on postsynaptic sites touching certain 
presynaptic elements, or when they are present on pre-
synaptic sites which terminate on postsynaptic neuronal 
elements [34].     
Importantly, these immunohistochemical findings 
corroborate our previous observations from pharmaco-
logical experiments, and additionally provide evidence 
for presence of NMDA and mGlu1 receptors in the ITR, 
which are apparently involved in its signaling pathways 
for neuromodulation of respiratory and cardiovascular 
functions. In these studies it has been shown that gluta-
mate injected into the ITR can elicit immediate apnea, 
prolong vagal reflex apnea induced by serotonin injection 
[12, 20, 21], and increase systolic blood pressure [13]. 
Furthermore, local non-selective blockade of ITR glu-
tamatergic receptors with kynurenic acid was able to sup-
press glutamate-induced central apnea and to increase 
reflex apnea evoked by systemic serotonin injection [12]. 
On the other hand, selective blockade of NMDA recep-
tors in the ITR was enough to abolish glutamate central 
apnea [20], while local selective antagonism of mGlu1 
prolonged reflex apnea without changing ITR response to 
glutamate stimulation [21]. Given these facts, presumed 
role of NMDA receptors, likely localized on somatic, 
postsynaptic sites in the ITR, is in mechanisms of damp-
ening acute transitory perturbations in pontine cardi-
orespiratory centers, while mGlu1 receptors, distributed 
on somato-dendritic sites of its neurons, are involved in 
modulation of cardiorespiratory reflexes induced by ex-
citations of vagal afferents.    
In summary, this study provides direct evidence for 
the presence of glutamatergic NMDA and mGlu1 re-
ceptors in the ITR, and thereby add in defining synaptic 
mechanisms involved in its regulation of respiratory and 
cardiovascular homeostasis together with other pontine 
and ventrolateral medullar structures.   
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